PR3-ANCA in Wegener's granulomatosis prime human mononuclear cells for enhanced activation via TLRs and NOD1/2

Diagnostic Pathology

Volumn 4, Issue 1, 2009, Pages

  Uehara, Akiko ^a   Sato, Tadasu ^a   Iwashiro, Atsushi ^a   Yokota, Sou ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68749110877     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-4-23     Document Type: Article

References (40)

1. Granulocyte-specific antinuclear factors in synovial fluids and sera from patients with rheumatoid arthritis. A Wiik E Jensen J Friis, Ann Rheum Dis 1974 33 6 515 522 4613286 10.1136/ard.33.6.515
2. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? DJ Davies JE Moran JF Niall GB Ryan, Br Med J (Clin Res Ed) 1982 285 6342 606 6297657 10.1136/bmj.285.6342.606
3. Vasculitis and glomerulonephritis: a subgroup with an antineutrophil cytoplasmic antibody. JB Hall BM Wadham CJ Wood V Ashton WR Adam, Aust N Z J Med 1984 14 3 277 278 6208890
4. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. FJ van der Woude N Rasmussen S Lobatto A Wiik H Permin LA van Es M van der Giessen GK van der Hem TH The, Lancet 1985 1 8426 425 429 2857806
5. Wegener's autoantigen decoded. DE Jenne J Tschopp J Ludemann B Utecht WL Gross, Nature 1990 346 6284 520 10.1038/346520a0 2377228
6. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. RJ Falk JC Jennette, N Engl J Med 1988 318 25 1651 1657 2453802
7. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. A Wiik, APMIS Suppl 1989 6 12 13 2660875
8. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. JW Tervaert FJ van der Woude AS Fauci JL Ambrus J Velosa WF Keane S Meijer M van der Giessen GK van der Hem TH The, Arch Intern Med 1989 149 11 2461 2465 10.1001/archinte.149.11.2461 2684074 (Pubitemid 19283202)
9. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. RJ Falk RS Terrell LA Charles JC Jennette, Proc Natl Acad Sci USA 1990 87 11 4115 4119 2161532 10.1073/pnas.87.11.4115 (Pubitemid 20217992)
10. Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generation. F Grimminger K Hattar C Papavassilis B Temmesfeld E Csernok WL Gross W Seeger U Sibelius, J Exp Med 1996 184 4 1567 1572 8879231 10.1084/jem.184.4.1567 (Pubitemid 26354715)
11. Pathophysiology of ANCA-associated glomerulonephritis. AC Muller Kobold YM van der Geld PC Limburg JW Tervaert CG Kallenberg, Nephrol Dial Transplant 1999 14 6 1366 1375 10.1093/ndt/14.6.1366 10382995 (Pubitemid 29241725)
12. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. CO Savage BE Pottinger G Gaskin CD Pusey JD Pearson, Am J Pathol 1992 141 2 335 342 1323218
13. Antibodies to neutrophil cytoplasmic antigens induce monocyte chemoattractant protein-1 secretion from human monocytes. BL Casselman KS Kilgore BF Miller JS Warren, J Lab Clin Med 1995 126 5 495 502 7595035
14. Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. DR Ralston CB Marsh MP Lowe MD Wewers, J Clin Invest 1997 100 6 1416 1424 9294107 10.1172/JCI119662
15. Upregulation of CD14 and CD18 on monocytes In vitro by antineutrophil cytoplasmic autoantibodies. R Nowack K Schwalbe LF Flores-Suarez B Yard FJ van der Woude, J Am Soc Nephrol 2000 11 9 1639 1646 10966488
16. Wegener's granulomatosis: antiproteinase 3 antibodies induce monocyte cytokine and prostanoid release-role of autocrine cell activation. K Hattar A Bickenbach E Csernok S Rosseau U Grandel W Seeger F Grimminger U Sibelius, J Leukoc Biol 2002 71 6 996 1004 12050185
17. A possible defective estimation of antineutrophil cytoplasmic antibodies in systemic lupus erythematosus due to the coexistence of periodontitis: preliminary observations. E Novo E Garcia-Mac Gregor S Nava L Perini, P R Health Sci J 1997 16 4 369 373 9547827
18. Interaction of antibodies to proteinase 3 (classic anti-neutrophil cytoplasmic antibody) with human renal tubular epithelial cells: impact on signaling events and inflammatory mediator generation. K Hattar U Grandel A Bickenbach A Schwarting WJ Mayet J Bux S Jessen C Fischer W Seeger F Grimminger, J Immunol 2002 168 6 3057 3064 11884479
19. Diagnostic and pathogenetic role of antineutrophil cytoplasmic autoantibodies. J Bartunkova V Tesar A Sediva, Clin Immunol 2003 106 2 73 82 10.1016/S1521-6616(02)00026-8 12672398 (Pubitemid 36369402)
20. Anti-proteinase 3 antibodies (c-ANCA) prime CD14-dependent leukocyte activation. K Hattar S van Burck A Bickenbach U Grandel U Maus J Lohmeyer E Csernok T Hartung W Seeger F Grimminger, J Leukoc Biol 2005 78 4 992 1000 10.1189/jlb.0902442 16006536 (Pubitemid 41384416)
21. Toll-like receptors in the induction of the innate immune response. A Aderem RJ Ulevitch, Nature 2000 406 6797 782 787 10.1038/35021228 10963608 (Pubitemid 30671237)
22. Phylogenetic perspectives in innate immunity. JA Hoffmann FC Kafatos CA Janeway RA Ezekowitz, Science 1999 284 5418 1313 1318 10.1126/science.284.5418. 1313 10334979 (Pubitemid 29289650)
23. Innate immune recognition. CA Janeway Jr R Medzhitov, Annu Rev Immunol 2002 20 197 216 10.1146/annurev.immunol.20.083001.084359 11861602 (Pubitemid 34293424)
24. Pathogen recognition and innate immunity. S Akira S Uematsu O Takeuchi, Cell 2006 124 4 783 801 10.1016/j.cell.2006.02.015 16497588 (Pubitemid 43261452)
25. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. M Chamaillard M Hashimoto Y Horie J Masumoto S Qiu L Saab Y Ogura A Kawasaki K Fukase S Kusumoto, Nat Immunol 2003 4 7 702 707 10.1038/ni945 12796777 (Pubitemid 36874448)
26. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. SE Girardin IG Boneca LA Carneiro A Antignac M Jehanno J Viala K Tedin MK Taha A Labigne U Zahringer, Science 2003 300 5625 1584 1587 10.1126/science.1084677 12791997 (Pubitemid 36682892)
27. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. N Inohara Y Ogura A Fontalba O Gutierrez F Pons J Crespo K Fukase S Inamura S Kusumoto M Hashimoto, J Biol Chem 2003 278 8 5509 5512 10.1074/jbc.C200673200 12514169 (Pubitemid 36800790)
28. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. SE Girardin IG Boneca J Viala M Chamaillard A Labigne G Thomas DJ Philpott PJ Sansonetti, J Biol Chem 2003 278 11 8869 8872 10.1074/jbc.C200651200 12527755 (Pubitemid 36800360)
29. Activation of human oral epithelial cells by neutrophil proteinase 3 through protease-activated receptor-2. A Uehara S Sugawara K Muramoto H Takada, J Immunol 2002 169 8 4594 4603 12370398
30. Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2. A Uehara K Muramoto H Takada S Sugawara, J Immunol 2003 170 11 5690 5696 12759451
31. Proinflammatory cytokines induce proteinase 3 as membrane-bound and secretory forms in human oral epithelial cells and antibodies to proteinase 3 activate the cells through protease-activated receptor-2. A Uehara Y Sugawara T Sasano H Takada S Sugawara, J Immunol 2004 173 6 4179 4189 15356169
32. Antibodies to proteinase 3 prime human monocytic cells via protease-activated receptor-2 and NF-kappaB for Toll-like receptor- and NOD-dependent activation. A Uehara A Iwashiro T Sato S Yokota H Takada, Mol Immunol 2007 44 14 3552 3562 10.1016/j.molimm.2007.03.010 17452051 (Pubitemid 46754446)
33. N2-(gamma-D-Glutamyl)-meso-2(L),2'(D)-diaminopimelic acid as the minimal prerequisite structure of FK-156: its acyl derivatives with potent immunostimulating activity. Y Kitaura O Nakaguchi H Takeno S Okada S Yonishi K Hemmi J Mori H Senoh Y Mine M Hashimoto, J Med Chem 1982 25 4 335 337 10.1021/jm00346a001 7069711 (Pubitemid 12078630)
34. Enhancement of TLR-mediated innate immune responses by peptidoglycans through NOD signaling. H Takada A Uehara, Curr Pharm Des 2006 12 32 4163 4172 10.2174/138161206778743510 17100619 (Pubitemid 44669745)
35. The treatment of Wegener's granulomatosis with trimethoprim/ sulfamethoxazole: illusion or vision? RA DeRemee, Arthritis Rheum 1988 31 8 1068 1074 10.1002/art.1780310821 3044373 (Pubitemid 18207977)
36. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. CA Stegeman JW Tervaert WJ Sluiter WL Manson PE de Jong CG Kallenberg, Ann Intern Med 1994 120 1 12 17 8250451
37. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. CA Stegeman JW Tervaert PE de Jong CG Kallenberg, N Engl J Med 1996 335 1 16 20 10.1056/NEJM199607043350103 8637536 (Pubitemid 26230808)
38. Neutrophil priming: pathophysiological consequences and underlying mechanisms. AM Condliffe E Kitchen ER Chilvers, Clin Sci (Lond) 1998 94 5 461 471 9682667
39. Neutrophil priming: the cellular signals that say 'amber' but not 'green'. MB Hallett D Lloyds, Immunol Today 1995 16 6 264 268 10.1016/0167-5699(95)80178-2 7662095
40. Are circulating neutrophils intravascularly activated in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides? AC Muller Kobold G Mesander CA Stegeman CG Kallenberg JW Tervaert, Clin Exp Immunol 1998 114 3 491 499 9844062 10.1046/j.1365-2249.1998.00748.x (Pubitemid 28539612)